au.\*:("VAN BREE J")
Results 1 to 16 of 16
Selection :
REGIOSPECIFICITY IN THE DIELS-ALDER REACTION OF 1,2,4-TRICHLORO-3,5,5-TRIMETHOXYCYCLOPENTADIENE.VAN BREE J; ANTEUNIS MJO.1978; BULL. SOC. CHIM. BELGES; BELG.; DA. 1978; VOL. 87; NO 2; PP. 135-142; BIBL. 13 REF.Article
Heteronuclear J-resolved solid-state NMR of filled natural rubberKENTGENS, A. P. M; VEEMAN, W. S; VAN BREE, J et al.Macromolecules. 1987, Vol 20, Num 6, pp 1234-1237, issn 0024-9297Article
Carrier-mediated transport of baclofen across monolayers of bovine brain endothelial cells in primary cultureVAN BREE, J. B. M. M; AUDUS, K. L; BORCHARDT, R. T et al.Pharmaceutical research. 1988, Vol 5, Num 6, pp 369-371, issn 0724-8741Article
Pharmacokinetic and pharmacodynamic data and models in clinical trialsSTEIMER, J.-L; EBELIN, M.-E; VAN BREE, J et al.European journal of drug metabolism and pharmacokinetics. 1993, Vol 18, Num 1, pp 61-76, issn 0378-7966Conference Paper
The pharmacokinetics of sandimmum neoral : a new oral formulation of cyclosporineHOLT, D. W; MUELLER, E. A; KOVARIK, J. M et al.Transplantation proceedings. 1994, Vol 26, Num 5, pp 2935-2939, issn 0041-1345Conference Paper
In vitro penetration of des-tyrosine1-D-phenylalanine3-β-casomorphin across the blood-brain barrierSTARK, H; VAN BREE, J. B. M. M; DE BOER, A. G et al.Peptides (New York, NY. 1980). 1992, Vol 13, Num 1, pp 47-51, issn 0196-9781Article
Development of specific antisera against 9-desglycinamide-8-arginine vasopressin by site-specific immunizationVAN BREE, J. B. M. M; VAN NISPEN, J. W; COOS VERHOEF, J et al.Journal of pharmaceutical sciences. 1991, Vol 80, Num 1, pp 46-49, issn 0022-3549, 4 p.Article
Aluminum effects on growth of brain microvessel endothelial cells in primary cultureAUDUS, K. L; HOLTHAUS, S. R; VAN BREE, J. M. B. B et al.Research communications in chemical pathology and pharmacology. 1988, Vol 60, Num 1, pp 71-85, issn 0034-5164Article
Stereoselective transport of baclofen across the blood-brain barrier in rats as determined by the unit impulse response methodologyVAN BREE, J. B. M. M; HEIJLIGERS-FEIJEN, C. D; DE BOER, A. G et al.Pharmaceutical research. 1991, Vol 8, Num 2, pp 259-262, issn 0724-8741, 4 p.Article
Transport of desglycinamide-arginine vasopressin across the blood-brain barrier in rats as evaluated by the unit impulse response methologyVAN BREE, J. B. M. M; TIO, S; DE BOER, A. G et al.Pharmaceutical research. 1990, Vol 7, Num 3, pp 293-298, issn 0724-8741Article
Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulationMUELLER, E. A; KOVARIK, J. M; VAN BREE, J. B et al.Pharmaceutical research. 1994, Vol 11, Num 2, pp 301-304, issn 0724-8741Article
Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients : a concentration-controlled comparison with the commercial formulationMUELLER, E. A; KOVARIK, J. M; VAN BREE, J. B et al.Transplantation. 1994, Vol 57, Num 8, pp 1178-1182, issn 0041-1337Article
Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patientsKOVARIK, J. M; KALLAY, Z; MUELLER, E. A et al.Transplant international. 1995, Vol 8, Num 5, pp 335-339, issn 0934-0874Article
Sparse-sampling optimal designs in pharmacokinetics and toxicokineticsMENTRE, F; BURTIN, P; MERLE, Y et al.Drug information journal. 1995, Vol 29, Num 3, pp 997-1019, issn 0092-8615Conference Paper
Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious ratsVAN HOOGDALEM, E. J; HEIJLIGERS-FEIJEN, C. D; MATHOT, R. A. A et al.The Journal of pharmacology and experimental therapeutics. 1989, Vol 251, Num 2, pp 741-744, issn 0022-3565Article
Radioimmunoassay of desglycinamide-arginine vasopressin and its application in a pharmacokinetic study in the ratVAN BREE, J. B. M. M; DE BOER, A. G; DANHOF, M et al.Peptides (New York, NY. 1980). 1988, Vol 9, Num 3, pp 555-559, issn 0196-9781Article